(Q82080591)

English

Measurement of the minimum apparent diffusion coefficient (ADCmin) of the primary tumor and CA125 are predictive of disease recurrence for patients with endometrial cancer

scientific article published on 18 October 2011

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22008707%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

Measurement of the minimum apparent diffusion coefficient (ADCmin) of the primary tumor and CA125 are predictive of disease recurrence for patients with endometrial cancer (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22008707%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

endometrial cancer

1 reference

based on heuristic

inferred from title

author name string

Keiichiro Nakamura

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22008707%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

Noriaki Imafuku

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22008707%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

Takeshi Nishida

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22008707%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

Ieyasu Niwa

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22008707%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

Ikuo Joja

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22008707%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

Atsushi Hongo

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22008707%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

Junichi Kodama

7

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22008707%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

Yuji Hiramatsu

8

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22008707%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

publication date

18 October 2011

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22008707%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

Gynecologic Oncology

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22008707%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

124

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22008707%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22008707%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

335-339

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22008707%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

Cancer statistics, 2011: the impact of eliminating socioeconomic and racial disparities on premature cancer deaths

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.10.014

7 January 2021

Relationship between surgical-pathological risk factors and outcome in clinical stage I and II carcinoma of the endometrium: a Gynecologic Oncology Group study.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.10.014

7 January 2021

Recurrent adenocarcinoma of the endometrium: a clinical and histopathological study of 379 patients

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.10.014

7 January 2021

Prognosis and treatment of endometrial cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.10.014

7 January 2021

Surgical pathologic spread patterns of endometrial cancer. A Gynecologic Oncology Group Study

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.10.014

7 January 2021

Lymphvascular space involvement--a prognostic indicator in endometrial adenocarcinoma

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.10.014

7 January 2021

Prognostic significance of gross myometrial invasion with endometrial cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.10.014

7 January 2021

Serum CA-125 level after 6 cycles of primary adjuvant chemotherapy is a useful prognostic factor for complete responders' survival in patients with advanced epithelial ovarian cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.10.014

7 January 2021

CA 125: a useful marker in endometrial carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.10.014

7 January 2021

Diffusion-weighted magnetic resonance imaging allows monitoring of anticancer treatment effects in patients with soft-tissue sarcomas

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.10.014

7 January 2021

Lymphomas and high-grade astrocytomas: comparison of water diffusibility and histologic characteristics

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.10.014

7 January 2021

Evaluation of liver diffusion isotropy and characterization of focal hepatic lesions with two single-shot echo-planar MR imaging sequences: prospective study in 66 patients

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.10.014

7 January 2021

Renal masses: characterization with diffusion-weighted MR imaging--a preliminary experience

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.10.014

7 January 2021

Role of diffusion-weighted magnetic resonance imaging for predicting of tumor invasiveness for clinical stage IA non-small cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.10.014

7 January 2021

Renal lesions: characterization with diffusion-weighted imaging versus contrast-enhanced MR imaging

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.10.014

7 January 2021

Diffusion-weighted MRI in the body: applications and challenges in oncology

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.10.014

7 January 2021

Longitudinal study of the assessment by MRI and diffusion-weighted imaging of tumor response in patients with locally advanced breast cancer undergoing neoadjuvant chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.10.014

7 January 2021

Diffusion-weighted MR imaging of uterine endometrial cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.10.014

7 January 2021

Diffusion-weighted MR imaging of female pelvic tumors: a pictorial review

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.10.014

7 January 2021

Myometrial invasion in endometrial cancer: diagnostic accuracy of diffusion-weighted 3.0-T MR imaging--initial experience.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.10.014

7 January 2021

Diffusion-weighted and perfusion MR imaging for brain tumor characterization and assessment of treatment response

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.10.014

7 January 2021

Apparent diffusion coefficients of benign and malignant salivary gland tumors. Comparison to histopathological findings

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.10.014

7 January 2021

Role of diffusion-weighted MR imaging in cervical lymphadenopathy.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.10.014

7 January 2021

Tumors in Pediatric Patients at Diffusion-weighted MR Imaging: Apparent Diffusion Coefficient and Tumor Cellularity

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.10.014

7 January 2021

Combined assay of serum levels of CA125 and CA19-9 in endometrial carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.10.014

7 January 2021

Value of preoperative CA 125 level in the management of uterine cancer and prediction of clinical outcome

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.10.014

7 January 2021

Preoperative evaluation of serum CA 125, TAG 72, and CA 15-3 in patients with endometrial carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.10.014

7 January 2021

Identifiers

10.1016/J.YGYNO.2011.10.014

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22008707%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22008707%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q82080591&oldid=1780604916"